Sarcoma Cancers

Soft TissueA Randomized, Blinded, Placebo-controlled, Phase 2 Study of INBRX-109 in Unresectable or Metastatic Conventional Chondrosarcoma
Bones and Joints, Soft TissueA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Study of Ivosidenib in Participants ≥18 Years of Age With Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
Soft TissueTesting Ipilimumab and Nivolumab Combination with or without Cabozantinib in People >= 18 Years Old with Advanced Soft Tissue Sarcoma
Bones and Joints, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Pediatrics, Phase IA Phase 1/2 Platform Study to Evaluate the Safety and Efficacy of Investigational Agents in Pediatric and Young Adult Participants with Hematologic Malignancies or Solid Tumors
Ill-Defined Sites, Soft TissueA Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients With High Risk RetroPeritoneal Sarcoma (RPS)